| Product Name | MF | CAS | Details |
|---|
| (2S,4S)-4-(Trifluoromethyl)pyrrolidine-2-carboxylic acid hydrochloride | C6H9ClF3NO2 | 1384424-55-8 | Details |
| PTGER1 antibody | Details |
| 2-(Piperazin-1-yl)-1-(pyrrolidin-1-yl)ethanone dihydrochloride | C10H21Cl2N3O | 1182708-84-4 | Details |
| A-889425 | C19H18F3N3O3S | 1072921-02-8 | Details |
| 1-[5-(Propan-2-yl)-4H-1,2,4-triazol-3-yl]methanamine | C6H12N4 | 944896-84-8 | Details |
| 2-Bromo-5-methylaniline | C7H8BrN | 53078-85-6 | Details |
| CA8 protein (His tag) | Details |
| 4-Nitrocinnamaldehyde | C9H7NO3 | 1734-79-8 | Details |
| 3,5-Dimethyl-1,2-dihydropyridine-2-thione | C7H9NS | 142274-34-8 | Details |
| LCN2 antibody (FITC) | Details |
| APOBEC3A antibody | Details |
| L-Valinol | C5H13NO | 2026-48-4 | Details |
| MHC Class I antibody | Details |
| 2-[(2-Aminoethyl)amino]acetic acid dihydrochloride | C4H12Cl2N2O2 | 25240-38-4 | Details |
| H-Asp-Val-OH | C9H16N2O5 | 13433-04-0 | Details |
| CGB protein (His tag) | Details |
| Brexpiprazole dihydrochloride | C25H28ClN3O2S | 913612-38-1 | Details |
| N-(3,3-Diethoxypropyl)-N-methylcyclopropanamine | C11H23NO2 | 1342862-07-0 | Details |
| 4(3H)-Pyrimidone | C4H4N2O | 51953-17-4 | Details |
| 3,3-Dimethylthiomorpholine-1,1-dioxide hydrochloride | C6H14ClNO2S | 1272667-54-5 | Details |
| 5-Bromo-2-ethoxybenzaldehyde | C9H9BrO2 | 79636-94-5 | Details |
| 1-Azido-2-(chloromethyl)benzene | C7H6ClN3 | 120692-81-1 | Details |
| YUKA1 | C13H16N4O2S | 708991-09-7 | Details |
| 4-[(2,3-Dimethylphenyl)methoxy]-3-methoxybenzaldehyde | C17H18O3 | 1443278-90-7 | Details |
| tert-Butyl 3,9-diazabicyclo[3.3.2]decane-9-carboxylate | C13H24N2O2 | 1050890-68-0 | Details |
| 6-(1H-1,2,4-Triazol-1-yl)pyridine-2-carboxylic acid | C8H6N4O2 | 1250552-50-1 | Details |
| Methyl 2-bromo-4-(cyanomethyl)benzoate | C10H8BrNO2 | 1252572-71-6 | Details |
| 5,7-difluoro-2,3-dihydrochromen-4-one | C9H6F2O2 | 844648-22-2 | Details |
| NR3C1 Blocking Peptide | Details |
| N1-Methyladenosine | C11H15N5O4 | 15763-06-1 | Details |
| 3-Azetidinyl phenyl ether hydrochloride | C9H12ClNO | 301335-39-7 | Details |
| TIRAP antibody | Details |
| 2-Fluoro-3-(trifluoromethyl)benzylamine | C8H7F4N | 239135-49-0 | Details |
| 3-Amino-8-methyl-1,3-diazaspiro[4.5]decane-2,4-dione | C9H15N3O2 | 16252-93-0 | Details |
| 2-Phenyl-1-(pyridin-4-yl)ethan-1-amine dihydrochloride | C13H14N2 | 118385-86-7 | Details |
| H-AYSSGAPPMPPF-OH | Details |
| Atorvastatin Cyclic Sodium Salt (Isopropyl) Impurity | C33H36FN2NaO7 | 1316291-19-6 | Details |
| Biotinyl-MCH (salmon) | C99H153N29O26S5 | Details |
| Poly(allylamine) solution - Average MW 15000 15 % aqueous solution | C3H7N | 30551-89-4 | Details |
| Virginiamycin M1 | C28H35N3O7 | 21411-53-0 | Details |
| N2-Benzyl-2,3-pyridinediamine | C12H13N3 | 32282-07-8 | Details |
| Nonyl b-D-maltopyranoside | C21H40O11 | 106402-05-5 | Details |
| 2-{[(4-Chlorophenyl)methyl]amino}-N-(2-fluorophenyl)acetamide | C15H14ClFN2O | 1038214-79-7 | Details |
| 5-Bromo-3-chloro-2-methyl-2H-indazole | C8H6BrClN2 | 1243288-50-7 | Details |
| rac-(2R,4R)-4-{[(tert-Butoxy)carbonyl]amino}oxane-2-carboxylic acid | C11H19NO5 | 2137817-97-9 | Details |
| 4-Bromo-2,5-dimethoxybenzene-1-sulfonyl chloride | C8H8BrClO4S | 1246776-82-8 | Details |
| tert-Butyl 2-amino-3,3,3-trifluoro-2-methylpropanoate hydrochloride | 2060042-55-7 | Details |
| tert-Butyl N-(octahydro-1H-isoindol-4-yl)carbamate | C13H24N2O2 | 479090-81-8 | Details |
| Methyl 2-acetyl-3-(4-pyridyl)propanoate | C11H13NO3 | 874583-30-9 | Details |
| N-(2-((5,5-dimethyl-3-oxocyclohex-1-enyl)amino)phenyl)-2-methylpropanamide | C18H24N2O2 | 104143-31-9 | Details |
| H-p-Phenyl-L-phenylalanine | C15H15NO2 | 155760-02-4 | Details |
| Octyl b-D-thiomaltopyranoside | C20H38O10S | 148616-91-5 | Details |
| 3-Iodo-L-thyronine | C15H14INO4 | 10468-90-3 | Details |
| 2,3,5,6-Tetramethyl-1,4-phenylenediamine | C10H16N2 | 3102-87-2 | Details |
| Treponema pallidum p17 protein | Details |
| CD86 antibody (Spectral Red) | Details |
| tert-Butyl 4-(4-aminobenzoyloxy)piperidine-1-carboxylate | C17H24N2O4 | 1235441-68-5 | Details |
| FHIT antibody | Details |
| 6-Bromo-4-chloro-2-(difluoromethyl)quinazoline | C9H4BrClF2N2 | 1341305-19-8 | Details |
| 2-Ethoxy-6-methylpyridin-3-amine | C8H12N2O | 1501925-63-8 | Details |
| Methyl 2-(tert-butylamino)acetate | C7H15NO2 | 53386-65-5 | Details |
| Methyl 6-(aminomethyl)-1H,3H,4H-pyrrolo[2,1-c][1,4]oxazine-8-carboxylate | C10H14N2O3 | 2155856-18-9 | Details |
| 4-cyclohexanecarbonylpiperazine-1-carbaldehyde | C12H20N2O2 | 928908-83-2 | Details |
| Cyclopropyl(4-fluoro-3-methylphenyl)methanamine | C11H14FN | 1018265-03-6 | Details |
| 1-Iodo-3-methanesulfonylbenzene | C7H7IO2S | 139769-20-3 | Details |
| rac-(3R,5R)-1-[(tert-Butoxy)carbonyl]-5-phenylpiperidine-3-carboxylic acid | C17H23NO4 | 1070661-25-4 | Details |
| Methyl N-[(1-methylpyrrolidin-3-yl)methyl]carbamate | 1592756-02-9 | Details |
| 3-(4-bromophenyl)-7-phenyl-2,6,7,8,4a-pentahydrocinnolin-5-one | C20H17BrN2O | 634155-12-7 | Details |
| 1-Octadecanoyl-2-(15S-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine | C43H78NO9P | 947381-58-0 | Details |
| 6-(2,3-Dihydro-1,4-benzodioxine-6-sulfonamido)hexanoic acid | C14H19NO6S | 304694-75-5 | Details |
| 2-Cyano-N-[4-(pyridin-4-yl)-1,3-thiazol-2-yl]acetamide | C11H8N4OS | 750599-34-9 | Details |
| 4-Methyl-2-phenylpyrrolidine | C11H15N | 891763-13-6 | Details |
| HIV1 integrase antibody | Details |
| PRPS2 Blocking Peptide | Details |
| 1-[4-(4-Bromophenyl)-1H-imidazol-2-yl]ethan-1-amine dihydrochloride | C11H13BrClN3 | 1258649-55-6 | Details |
| 3-(Propan-2-yl)cyclohexan-1-amine | C9H19N | 6850-37-9 | Details |
| Methyl({1-[(5-methylthiophen-2-yl)methyl]pyrrolidin-3-yl}methyl)amine dihydrochloride | C12H21ClN2S | 1808547-85-4 | Details |
| rac-(3R,4S)-3-Methoxy-4-methylpiperidine hydrochloride | C7H16ClNO | 374794-73-7 | Details |
| Ferritin light chain protein | Details |
| Methyl 3-amino-4-chloro-2-methylbenzoate | C9H10ClNO2 | 190367-58-9 | Details |
| ORAV1 antibody | Details |
| (4S)-6-Ethyl-3,4-dihydro-2H-1-benzopyran-4-ol | C11H14O2 | 1567875-21-1 | Details |
| MMP24 Blocking Peptide | Details |
| Click EB1 | Details |
| 4-tert-Butyl-3-thiosemicarbazide | C5H13N3S | 13431-39-5 | Details |
| tert-Butyl 1H,4H,5H,6H,7H-pyrrolo[3,2-c]pyridine-1-carboxylate | C12H18N2O2 | 1820684-09-0 | Details |
| Methyl 3-hydroxy-2-methyl-2-phenylpropanoate | C11H14O3 | 70397-74-9 | Details |
| {[(1-Bromo-2-methylpropan-2-yl)oxy]methyl}benzene | C11H15BrO | 29840-16-2 | Details |
| ((4-chloro-2-nitrophenyl)sulfonyl)(3-phenylpropyl)amine | C15H15ClN2O4S | 1024179-40-5 | Details |
| 2-(4-Chlorobenzoyl)pyrimidine | C11H7ClN2O | 64385-81-5 | Details |
| 1-(3-Bromophenyl)-2-(1H-imidazol-1-yl)ethan-1-ol | C11H11BrN2O | 912962-95-9 | Details |
| 4-(Aminomethyl)-N-[2-(dimethylamino)ethyl]benzamide dihydrochloride | C12H20ClN3O | 1258640-02-6 | Details |
| N-[5-(Pyrrolidin-2-yl)-1,3,4-oxadiazol-2-yl]acetamide hydrochloride | C8H13ClN4O2 | 1803597-80-9 | Details |
| VULM 1457 | C25H27N3O3S | 228544-65-8 | Details |
| 3-Cyclopropyl-1-(2,2,2-trifluoroethyl)-1H-pyrazole-4-carboxylic acid | C9H9F3N2O2 | 1006486-60-7 | Details |
| 4-(4-Chloropyridine-2-carbonyl)morpholine | C10H11ClN2O2 | 1094306-26-9 | Details |
| Recombinant SARS-CoV-2, RBD Protein (Delta, B1.617.2, India Variant ) | Details |
| 4-chloro-N,N-dimethyl-3-nitrobenzenesulfonamide | C8H9ClN2O4S | 137-47-3 | Details |
| Goat anti Human Kappa Chain (Alk Phos) | Details |
| Mnk1 active human | 191359-13-4 | Details |
| Product Total： Product Page： | ||||
| 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 | ||||